Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-22 3:09 pm Purchase | 2025-12-15 | 13G | Elauwit Connection, Inc. Common Stock ELWT | LYTTON LAURENCE W | 390,879 5.900% | 390,879 (New Position) | Filing History |
| 2025-11-17 7:16 pm Purchase | 2025-11-13 | 13G | Aprea Therapeutics, Inc. APRE | LYTTON LAURENCE W | 681,837 9.900% | 681,837 (New Position) | Filing History |
| 2025-11-14 2:12 pm Sale | 2025-09-30 | 13G | TELA Bio, Inc. TELA | LYTTON LAURENCE W | 2,865,305 7.200% | -558,886 (-16.32%) | Filing History |
| 2025-11-14 1:32 pm Purchase | 2025-09-30 | 13G | Sonim Technologies, Inc. SONM | LYTTON LAURENCE W | 79,941 7.800% | 25,082 (+45.72%) | Filing History |
| 2025-11-14 1:30 pm Sale | 2025-09-30 | 13G | scPharmaceuticals Inc. SCPH | LYTTON LAURENCE W | 0 0.000% | -2,944,932 (Position Closed) | Filing History |
| 2025-11-14 1:29 pm Sale | 2025-09-30 | 13G | MDxHealth S.A. MDXH | LYTTON LAURENCE W | 3,163,286 6.400% | -786,099 (-19.90%) | Filing History |
| 2025-11-14 1:28 pm Purchase | 2025-09-30 | 13G | LiqTech International, Inc. LIQT | LYTTON LAURENCE W | 1,058,508 9.990% | 468,855 (+79.51%) | Filing History |
| 2025-11-14 1:26 pm Purchase | 2025-09-30 | 13G | Aytu BioPharma, Inc. AYTU | LYTTON LAURENCE W | 1,086,522 9.990% | 579,917 (+114.47%) | Filing History |
| 2025-10-30 12:03 pm Purchase | 2025-10-28 | 13G | Creative Realities, Inc. CREX | LYTTON LAURENCE W | 534,436 5.100% | 93,134 (+21.10%) | Filing History |
| 2025-09-16 2:11 pm Purchase | 2025-09-10 | 13G | Talphera, Inc. TLPH | LYTTON LAURENCE W | 3,636,364 8.000% | 3,636,364 (New Position) | Filing History |
| 2025-08-25 6:33 pm Purchase | 2024-03-28 | 13G | Guerrilla RF, Inc. GUER | LYTTON LAURENCE W | 1,088,179 9.990% | 1,088,179 (New Position) | Filing History |
| 2025-08-14 6:12 pm Purchase | 2025-06-30 | 13G | Cellectar Biosciences, Inc. CLRB | LYTTON LAURENCE W | 51,391 1.600% | 51,391 (New Position) | Filing History |
| 2025-08-14 3:08 pm Purchase | 2025-06-30 | 13G | TELA Bio, Inc. TELA | LYTTON LAURENCE W | 3,424,191 8.500% | 971,934 (+39.63%) | Filing History |
| 2025-08-14 1:56 pm Sale | 2025-06-30 | 13G | Creative Realities, Inc. CREX | LYTTON LAURENCE W | 441,302 4.200% | -83,061 (-15.84%) | Filing History |
| 2025-08-14 1:54 pm Sale | 2025-06-30 | 13G | Electrovaya Inc. ELVA | LYTTON LAURENCE W | 1,898,922 4.700% | -544,387 (-22.28%) | Filing History |
| 2025-08-14 1:51 pm Sale | 2025-06-30 | 13G | Exagen Inc. XGN | LYTTON LAURENCE W | 216,840 1.000% | -936,648 (-81.20%) | Filing History |
| 2025-07-09 6:07 pm Sale | 2025-07-07 | 13G | Sonim Technologies, Inc. SONM | LYTTON LAURENCE W | 54,859 5.600% | -11,807 (-17.71%) | Filing History |
| 2025-07-02 7:48 pm Sale | 2025-06-30 | 13G | Sonim Technologies, Inc. SONM | LYTTON LAURENCE W | 66,667 11.200% | -48,162 (-41.94%) | Filing History |
| 2025-06-13 2:09 pm Purchase | 2025-06-09 | 13G | Aytu BioPharma, Inc. AYTU | LYTTON LAURENCE W | 506,605 5.600% | 506,605 (New Position) | Filing History |
| 2025-05-16 5:41 pm Purchase | 2025-05-12 | 13G | Sonim Technologies, Inc. SONM | LYTTON LAURENCE W | 114,829 19.300% | 66,667 (+138.42%) | Filing History |